Relationship between clinical findings and genetic mutations in patients with familial Mediterranean fever

• Published in: Pediatric rheumatology online journal Vol. 13; no. 56; p. 59
• Main Authors: Kilic, Ayse, Varkal, Muhammet Ali, Durmus, Mehmet Sait, Yildiz, Ismail, Yıldırım, Zeynep Nagihan Yürük, Turunc, Gorkem, Oguz, Fatma, Sidal, Mujgan, Omeroglu, Rukiye Eker, Emre, Sevinc, Yilmaz, Yasin, Kelesoglu, Fatih Mehmet, Gencay, Genco Ali, Temurhan, Sonay, Aydin, Filiz, Unuvar, Emin
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 12.12.2015; BioMed Central
• Subjects: Abdominal Pain - etiology; Care and treatment; Chest Pain - etiology; Child; Child, Preschool; Cross-Sectional Studies; Familial Mediterranean fever; Familial Mediterranean Fever - complications; Familial Mediterranean Fever - genetics; Familial Mediterranean Fever - pathology; Female; Fever - etiology; Gene mutations; Health aspects; Humans; Infant; Male; Mutation; Patients; Pericardial Effusion - etiology; Retrospective Studies; Risk factors; Severity of Illness Index; Turkey
• ISSN: 1546-0096; 1546-0096
• DOI: 10.1186/s12969-015-0057-1

Familial Mediterranean fever (FMF) is one of the most frequent genetic diseases encountered in the Mediterranean region. We aimed to investigate the correlation between genetic mutations and the clinical findings in 562 patients with FMF. In this retrospective cross-sectional study conducted with patients' files between 2006, and 2013, reverse hybridization assay for MEFV gene mutations was used and the 12 most frequent mutations were screened. Mutation types and clinical findings were compared with variance analysis. The mean age was 6.9 ± 3.4 years (range, 1.8-11.6 years). The most common symptom was fever (97.3%). Thirty-four of the patients (6.04%) were admitted with periodic fever only. Of these patients, M694V was the most common mutation type (73.5%). The percentage of the patients predominantly presenting with recurrent abdominal pain was 77.78% and the most frequent mutations were M694V and E148Q. The rate of arthritis and arthralgia was significantly higher in patients with M694V and E148Q mutations. Chest pain was reported more often in patients homozygous for M694V (61.4%). Pericardial effusion was documented in the echocardiography of 10.9% of the 229 children with chest pain. Some patients had both FMF and Henoch Schönlein purpura (HSP), and were more likely to harbor either homozygote M694V or E148Q mutations. The frequency of episodes was higher in patients with homozygous M694V mutations (number of attacks = 4.4 ± 1.6/month). Proteinuria was detected in 106 patients of cases (29.2%), at an average of 854 ± 145 mg/L. Most of the patients with proteinuria and elevated serum amyloid-A had homozygous M694V mutation. The most common mutation in children in Turkey with FMF is the M694V mutation. Recurrent abdominal pain, arthritis or arthralgia, chest pain, and pericarditis were commonly seen in patients with M694V and E148Q mutations.